Literature DB >> 12167558

Insights from a three-dimensional model into ligand binding to constitutive active receptor.

Li Xiao1, Xiaoming Cui, Vincent Madison, Ronald E White, K-C Cheng.   

Abstract

Two orphan nuclear receptors, constitutive active (or androstane) receptor (CAR) and pregnane X receptor (PXR), are among the most important mediators of ligand-activated transcriptional induction of liver microsomal cytochrome P450 drug-metabolizing enzymes. CAR and PXR belong to the same NR1I receptor subfamily and show high sequence homology to each other. The vitamin D receptor (VDR) also belongs to the NR1I subfamily and has the second highest homology to CAR in the ligand binding domain. A 3D model of the ligand binding domain of human CAR (hCAR) was constructed based on the available X-ray structures of human PXR (hPXR) and VDR (hVDR). The model shows that the size of the ligand binding cavities of hCAR and hPXR are similar, but larger than that of hVDR. hPXR's capability of binding to extremely large ligands, such as rifampicin, implies that its binding cavity may be able to expand further through the flexibility of a surface loop. In contrast, hCAR does not have this loop so that its cavity cannot expand, suggesting that hCAR would not bind to the largest hPXR ligands. Docking calculations of selected ligands to hCAR, based on the structural model, are consistent with previously reported receptor binding data. The results from this study indicate that structural modeling will be a useful tool for understanding ligand binding to hCAR and for design of drugs free of hCAR-mediated enzyme induction.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12167558     DOI: 10.1124/dmd.30.9.951

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  7 in total

1.  Genome-wide analysis of human constitutive androstane receptor (CAR) transcriptome in wild-type and CAR-knockout HepaRG cells.

Authors:  Daochuan Li; Bryan Mackowiak; Timothy G Brayman; Michael Mitchell; Lei Zhang; Shiew-Mei Huang; Hongbing Wang
Journal:  Biochem Pharmacol       Date:  2015-08-12       Impact factor: 5.858

2.  Molecular dynamics simulations of the human CAR ligand-binding domain: deciphering the molecular basis for constitutive activity.

Authors:  Björn Windshügel; Johanna Jyrkkärinne; Antti Poso; Paavo Honkakoski; Wolfgang Sippl
Journal:  J Mol Model       Date:  2004-12-23       Impact factor: 1.810

Review 3.  CAR and PXR: the xenobiotic-sensing receptors.

Authors:  Yoav E Timsit; Masahiko Negishi
Journal:  Steroids       Date:  2006-12-20       Impact factor: 2.668

Review 4.  Current industrial practices in assessing CYP450 enzyme induction: preclinical and clinical.

Authors:  Michael Sinz; Gillian Wallace; Jasminder Sahi
Journal:  AAPS J       Date:  2008-08-07       Impact factor: 4.009

5.  Phosphorylation Modulates the Coregulatory Protein Exchange of the Nuclear Receptor Pregnane X Receptor.

Authors:  Wenqi Cui; Xunan Shen; Emre Agbas; Brandon Tompkins; Hadley Cameron-Carter; Jeff L Staudinger
Journal:  J Pharmacol Exp Ther       Date:  2020-03-23       Impact factor: 4.030

6.  The evolution of drug-activated nuclear receptors: one ancestral gene diverged into two xenosensor genes in mammals.

Authors:  Christoph Handschin; Sharon Blättler; Adrian Roth; Renate Looser; Mikael Oscarson; Michel R Kaufmann; Michael Podvinec; Carmela Gnerre; Urs A Meyer
Journal:  Nucl Recept       Date:  2004-10-12

Review 7.  Utility of homology models in the drug discovery process.

Authors:  Alexander Hillisch; Luis Felipe Pineda; Rolf Hilgenfeld
Journal:  Drug Discov Today       Date:  2004-08-01       Impact factor: 7.851

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.